Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Atrium Health looking to scoop up smaller nonprofit health system in $2B deal
WakeMed, a three-hospital system in the North Carolina capital region of Raleigh, would become part of Advocate Health, Atrium’s parent company, if the deal goes through. Advocate is one of the largest not-for-profit health systems in the U.S.
Johnson & Johnson becomes the latest pharmaceutical company to sign on to TrumpRx
The New Jersey-based drug developer joins AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer in offering products directly to patients at a discounted rate. Johnson & Johnson is currently listing four medications on the platform.
FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs
The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.
Virtual nursing staff may help save cardiology departments from burnout
The idea is spreading thanks to a new startup focused on providing support for cardiologists.
FTC settles antitrust lawsuit against private equity-backed anesthesiology chain
Federal regulators alleged that U.S. Anesthesia Partners—a portfolio company of Welsh, Carson, Anderson & Stowes—engaged in a “roll-up scheme” in Texas that effectively eliminated the competition. The company denies the allegations, but has agreed to undisclosed terms that would see the lawsuit resolved.

Private-payer billings not radiology’s revenue category to lead

Going by claims submitted to commercial insurers, radiology ranks 15th out of 18 physician specialties.

FDA clears prostate AI for second indication

Radiology AI vendor Bot Image may market its prostate software not only for diagnosing cancer when suspected but also for performing prostate screenings.

7 lessons learned during joint big business/healthcare AI projects

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

Johnson & Johnson scraps RSV vaccine after trial

The move comes as RSV has been on the rise in the United States.

UnitedHealthcare to cut back on prior authorization paperwork

UnitedHealthcare announced it would remove 20% of its current prior authorizations starting with the third quarter of this year.

CDC warns of new deadly super fungus

The emerging fungus, Candida auris (C. auris), has been spreading across healthcare facilities at an “alarming rate,” according to the CDC.

IR proves strong on practicality, profitability—but some cost-inclusive metrics remain to be shown

Recent evidence confirms that interventional radiology produces solid clinical outcomes while beating surgery on the cost-effectiveness of numerous procedures.

ACC Vice President Cathie Biga discusses OBLs and ASCs during the ACC23 meeting. #ACC #OBLs #ASCs #ACC23

What the rise of outpatient cardiac OBLs and ASCs means for cardiology

To reduce the healthcare costs associated with straightforward, minimally invasive cardiovascular procedures, more and more ambulatory surgical centers and office based labs are opening all over the United States.

Business Intelligence

Atrium Health looking to scoop up smaller nonprofit health system in $2B deal

Johnson & Johnson becomes the latest pharmaceutical company to sign on to TrumpRx

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs

Virtual nursing staff may help save cardiology departments from burnout

FTC settles antitrust lawsuit against private equity-backed anesthesiology chain